pyridazine has been researched along with Anasarca in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Maki, Y; Sato, M; Takaya, M; Tanizawa, H; Terashima, K | 1 |
Ahmed, EM; El-Malah, AA; Hassan, MSA; Kassab, AE | 1 |
Ahmed, EM; Khalil, NA; Mohamed, KO; Nissan, YM; Zaitone, SA | 1 |
Abouzid, KA; Ahmed, EM; Khalil, NA; Zaitone, SA | 1 |
4 other study(ies) available for pyridazine and Anasarca
Article | Year |
---|---|
A new nonsteroidal analgesic-antiinflammatory agent. Synthesis and activity of 4-ethoxy-2-methyl-5-morpholino-3(2H)-pyridazinone and related compounds.
Topics: Acetates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Edema; Lethal Dose 50; Male; Mice; Morpholines; Pyridazines; Rats; Structure-Activity Relationship | 1979 |
New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Design; Edema; Humans; Male; Molecular Docking Simulation; Molecular Structure; Pyridazines; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Structure-Activity Relationship | 2020 |
Synthesis and biological evaluation of new pyrazolone-pyridazine conjugates as anti-inflammatory and analgesic agents.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Cytokines; Dose-Response Relationship, Drug; Edema; Humans; Mice; Models, Molecular; Molecular Structure; Pyrazolones; Pyridazines; Structure-Activity Relationship | 2014 |
Synthesis and biological evaluation of new heteroaryl carboxylic acid derivatives as anti-inflammatory-analgesic agents.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Cyclooxygenase 2; Drug Evaluation, Preclinical; Edema; Interleukin-6; Mice; Nicotinic Acids; Niflumic Acid; Pyridazines; Rats; Tumor Necrosis Factor-alpha; Ulcer | 2013 |